A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and mechanic. But as the years went on, he began to notice his body changing in ...

This latest New Frontiers installment delves into Acromegaly Community Inc.’s ongoing mission to provide education, resources, and an inclusive support system for those living with Acromegaly. Viewers ...

Tanya Angus had worst acromegaly in world, growing to 7-feet tall, 400 lbs. Jan. 14, 2013— -- Tanya Angus, the Las Vegas woman who had the worst case of gigantism in the world, died today, ...

What Is Palsonify, and Why Does It Matter? Palsonify (paltusotine) is a new once-daily oral medicine approved to treat adults with acromegaly who either didn’t get much help from surgery or cannot ...

After nearly two decades in the endocrine scene, Crinetics is making its commercial debut with the approval of a game-changing treatment for the rare growth disorder acromegaly. The FDA on Thursday ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved paltusotine for first-line treatment of patients with acromegaly who did not respond to or ...

Please provide your email address to receive an email when new articles are posted on . Once-monthly subcutaneous octreotide was associated with persistent control of IGF-I and growth hormone levels ...

Gigantism and acromegaly are growth disorders that result from excess amounts of growth hormone in the body. The conditions are similar but have several differences. Growth hormone is one of the ...

An investigational treatment for acromegaly -- also known as gigantism -- was safe and boosted biochemical control, according to final topline findings of the phase III ACROINNOVA 2 study. Meeting the ...